Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Analgecine for Low Back Pain: a Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter Trial

NCT02168010 is registered in ClinicalTrials.gov with VanWorld Pharmaceutical (Rugao) Company Limited as lead sponsor.

NCT NCT02168010
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02168010 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Analgecine for Low Back Pain: a Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter Trial
Lead sponsor
VanWorld Pharmaceutical (Rugao) Company Limited
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2013
Completion date
July 31, 2014
Enrollment
584 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

low back pain